Atherosclerosis / triglyceride

Method of treating atherosclerosis in high triglyceride subjects

Apenas usuários registrados podem traduzir artigos

Entrar Inscrever-se

BACKGROUND OF THE INVENTION This invention relates to method of use of inhibitors of cholesteryl ester transfer protein (CETP) in subjects with high triglyceride level, for raising certain plasma lipid levels, including high density lipoprotein (HDL)-cholesterol and for lowering other plasma lipid

Compositions and methods for reducing or controlling blood cholesterol, lipoproteins, triglycerides and atherosclerosis

Apenas usuários registrados podem traduzir artigos

Entrar Inscrever-se

FIELD OF INVENTION This invention relates to compounds and methods that reduce or control levels of cholesterol and triglycerides and their oxidation to lipid peroxidases, thus preferably inhibiting or arresting the development of atherosclerosis and restenosis when administered to mammals,

Compositions and methods for reducing or controlling blood cholesterol, lipoproteins, triglycerides and atherosclerosis

Apenas usuários registrados podem traduzir artigos

Entrar Inscrever-se

FIELD OF INVENTION This invention relates to compounds and methods that reduce or control levels of cholesterol and triglycerides and their oxidation to lipid peroxidases, thus preferably inhibiting or arresting the development of atherosclerosis and restenosis when administered to mammals,

Compositions and methods for reducing or controlling blood cholesterol, lipoproteins, triglycerides and atherosclerosis

Apenas usuários registrados podem traduzir artigos

Entrar Inscrever-se

FIELD OF INVENTION This invention relates to compounds and methods that reduce or control levels of cholesterol and triglycerides and their oxidation to lipid peroxidases, thus preferably inhibiting or arresting the development of atherosclerosis and restenosis when administered to mammals,

Compositions and methods for reducing or controlling blood cholesterol, lipoproteins, triglycerides and atherosclerosis

Apenas usuários registrados podem traduzir artigos

Entrar Inscrever-se

FIELD OF INVENTION This invention relates to compounds and methods that reduce or control levels of cholesterol and triglycerides and their oxidation to lipid peroxidases, thus preferably inhibiting or arresting the development of atherosclerosis and restenosis when administered to mammals,

Compositions and methods for reducing or controlling blood cholesterol, lipoproteins, triglycerides and atherosclerosis

Apenas usuários registrados podem traduzir artigos

Entrar Inscrever-se

FIELD OF INVENTION This invention relates to compounds and methods that reduce or control levels of cholesterol and triglycerides and their oxidation to lipid peroxidases, thus preferably inhibiting or arresting the development of atherosclerosis and restenosis when administered to mammals,

Compositions and methods for reducing or controlling blood cholesterol, lipoproteins, triglycerides and atherosclerosis

Apenas usuários registrados podem traduzir artigos

Entrar Inscrever-se

FIELD OF INVENTION This invention relates to compounds and methods that reduce or control levels of cholesterol and triglycerides and their oxidation to lipid peroxidases, thus preferably inhibiting or arresting the development of atherosclerosis and restenosis when administered to mammals,

Method to counter oxidation of LDL, decrease triglyceride or cholesterol and inhibit atherosclerosis using Hibiscus sabdariffa extract

Apenas usuários registrados podem traduzir artigos

Entrar Inscrever-se

BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to the novel applications of the Hibiscus sabdariffa extract in countering oxidization of low density lipoproteins, reducing cholesterol or triglyceride in plasma or inhibiting atherosclerosis. 2. Description of the

Compositions and methods for treating and preventing hyperlipidemia, fatty liver, atherosclerosis and other disorders associated with metabolic syndrome

Apenas usuários registrados podem traduzir artigos

Entrar Inscrever-se

FIELD The invention relates generally to the fields of biochemistry, cell biology, molecular genetics, endocrinology, and cardiovascular medicine. BACKGROUND Contemporary Western type diets challenge lipid and glucose homeostasis by overloading blood with cholesterol, triglycerides, and glucose.

Compositions and methods for treating and preventing hyperlipidemia, fatty liver, atherosclerosis and other disorders associated with metabolic syndrome

Apenas usuários registrados podem traduzir artigos

Entrar Inscrever-se

FIELD The invention relates generally to the fields of biochemistry, cell biology, molecular genetics, endocrinology, and cardiovascular medicine. BACKGROUND Contemporary Western type diets challenge lipid and glucose homeostasis by overloading blood with cholesterol, triglycerides, and glucose.

Compositions and methods for treating and preventing hyperlipidemia, fatty liver, atherosclerosis and other disorders associated with metabolic syndrome

Apenas usuários registrados podem traduzir artigos

Entrar Inscrever-se

FIELD The invention relates generally to the fields of biochemistry, cell biology, molecular genetics, endocrinology, and cardiovascular medicine. BACKGROUND Contemporary Western type diets challenge lipid and glucose homeostasis by overloading blood with cholesterol, triglycerides, and glucose.

Compositions and methods for treating and preventing hyperlipidemia, fatty liver, atherosclerosis and other disorders associated with metabolic syndrome

Apenas usuários registrados podem traduzir artigos

Entrar Inscrever-se

FIELD The invention relates generally to the fields of biochemistry, cell biology, molecular genetics, endocrinology, and cardiovascular medicine. BACKGROUND Contemporary Western type diets challenge lipid and glucose homeostasis by overloading blood with cholesterol, triglycerides, and glucose.

Method, reagent and kit for evaluating susceptibility to premature atherosclerosis

Apenas usuários registrados podem traduzir artigos

Entrar Inscrever-se

BACKGROUND OF THE INVENTION This application relates to a method, reagent and kit for evaluating susceptibility to and causation of premature atherosclerosis and other forms of coronary artery disease. The invention further relates to a method of gene therapy by which lipoprotein lipase deficiencies

Gene therapy method for reducing risk of atherosclerosis

Apenas usuários registrados podem traduzir artigos

Entrar Inscrever-se

BACKGROUND OF THE INVENTION This application relates to a method, reagent and kit for evaluating susceptibility to and causation of premature atherosclerosis and other forms of coronary artery disease. The invention further relates to a method of gene therapy by which lipoprotein lipase deficiencies

Multibinding inhibitors of microsomal triglyceride transferase protein

Apenas usuários registrados podem traduzir artigos

Entrar Inscrever-se

BACKGROUND OF THE INVENTION 1. Field of the Invention This invention relates to novel multibinding compounds (agents) that inhibit microsomal triglyceride transferase protein (MTP) and to pharmaceutical compositions comprising such compounds. Accordingly, the multibinding compounds and

atherosclerosis/triglyceride

Method of treating atherosclerosis in high triglyceride subjects

Compositions and methods for reducing or controlling blood cholesterol, lipoproteins, triglycerides and atherosclerosis

Compositions and methods for reducing or controlling blood cholesterol, lipoproteins, triglycerides and atherosclerosis

Compositions and methods for reducing or controlling blood cholesterol, lipoproteins, triglycerides and atherosclerosis

Compositions and methods for reducing or controlling blood cholesterol, lipoproteins, triglycerides and atherosclerosis

Compositions and methods for reducing or controlling blood cholesterol, lipoproteins, triglycerides and atherosclerosis

Compositions and methods for reducing or controlling blood cholesterol, lipoproteins, triglycerides and atherosclerosis

Method to counter oxidation of LDL, decrease triglyceride or cholesterol and inhibit atherosclerosis using Hibiscus sabdariffa extract

Compositions and methods for treating and preventing hyperlipidemia, fatty liver, atherosclerosis and other disorders associated with metabolic syndrome

Compositions and methods for treating and preventing hyperlipidemia, fatty liver, atherosclerosis and other disorders associated with metabolic syndrome

Compositions and methods for treating and preventing hyperlipidemia, fatty liver, atherosclerosis and other disorders associated with metabolic syndrome

Compositions and methods for treating and preventing hyperlipidemia, fatty liver, atherosclerosis and other disorders associated with metabolic syndrome

Method, reagent and kit for evaluating susceptibility to premature atherosclerosis

Gene therapy method for reducing risk of atherosclerosis

Multibinding inhibitors of microsomal triglyceride transferase protein

O mais completo banco de dados de ervas medicinais apoiado pela ciência